NCT05860439View on ClinicalTrials.gov

Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

May 1, 2023

Study Completion Date

June 1, 2023

Conditions
Telangiectasis
Interventions
PROCEDURE

Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)

Patients previously treated were reassessed for long-term follow-up.

Trial Locations (1)

18607030

Sao Paulo State University Botucatu Campus, Botucatu

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

UPECLIN HC FM Botucatu Unesp

OTHER

NCT05860439 - Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias | Biotech Hunter | Biotech Hunter